Three-year follow-up study of women who participated in a cervical cancer screening intervention while in prison

Canadian Journal of Public Health

Volumn 99, Issue 4, 2008, Pages 262-266

  Martin, Ruth Elwood ^a   Hislop, T Gregory ^a,b   Moravan, Veronika ^b   Grams, Garry D ^a   Calam, Betty ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Prisoners; Screening; Uterine cervical dysplasia; Women

Indexed keywords

EID: 50949116937     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403751     Document Type: Article

References (15)

1. Fox P, Arnsberger P, Zhang X. An examination of differential follow-up rates in cervical cancer screening. J Community Health 1997;22:199-209.
2. Hodge FS, Fredericks L, Rodriguez B. American Indian women's talking circle. A cervical cancer screening and prevention project. Cancer 1996;78:1592-97.
3. Abercrombie PD. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonatal Nurs 2001;30:80-88.
4. Lindau ST, Basu A, Leitsch SA. Health literacy as a predictor of follow-up after an abnormal Pap smear: A prospective study. J Gen Intern Med 2006;21:829-34.
5. Bickell NA, Vermund SH, Holmes M, Safyer S, Burk RD. Human papillomavirus, gonorrhea, syphilis, and cervical clysplasia in jailed women. Am J Public Health 1991;81:1318-20.
6. de Sanjose S, Valls I, Paz Canadas M, Lloveras B, Quintana MJ, Shah KV, Bosch FX. Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners. Medicina Clinica 2000; 115:81-84.
7. Rohan TE, Henson DE, Franco EL, Albores-Saavedra J. Cancer precursors. In: Schottenfeld D, Fraumeni JF Jr. (Eds.), Cancer Epidemiology and Prevention, third edition. New York, NY: Oxford University Press, 2006;33.
8. Plugge E, Fitzpatrick R. Factors affecting cervical screening uptake in prisoners. J Med Screening 2004;11:48-49.
9. Martin RE. A review of a prison cervical cancer screening program in British Columbia. Can J Public Health 1998;89:382-86.
10. Elwood Martin R, Hislop TG, Grams GD, Calam B, Jones E, Moravan V. Evaluation of a cervical cancer screening intervention for prison inmates. Can J Public Health 2004;95:285-89.
11. BC Cancer Agency. Cervical Cancer Screening Program 2005 Annual Report. Vancouver, BC. Available online at: www.bccancer.bc.ca/PPI/Screening/ Cervical (Accessed February 15, 2007).
12. Martin RE, Hislop TG, Grams GD, Moravan V, Calam B. Beware of multiple names in database linkage research: Prevalence of aliases in female prison population. BMJ 2005;331:335-36.
13. Taylor VM, Hislop TG, Jackson JC, Tu SP, Yasui Y, Schwartz SM, et al. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North, America. J Nad Cancer Inst 2002;94:670-77.
14. Hunt LM, De Voogd KB, Soucy MD, Longworth JC. Exploring loss to follow-up: Abnormal Pap screening in Hispanic patients. Cancer Pract 2002; 10: 122-29.
15. Johnson SL, Van de Ven JTC, Grant BA. Institutional methadone maintenance treatment: Impact on release outcorne and institutional behaviour. Correctional Service Canada, Research Branch, 2001. Available online at: http://amicus.collectionscanada.ca/electroniccollection-bin/ Main/RouteRqst (Accessed February 15, 2007).